Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists

GA Silvestri, MP Rivera - Chest, 2005 - Elsevier
Lung cancer is the most common cause of cancer death. The vast majority of patients
present with non-small cell lung cancer (NSCLC) in advanced inoperable stages. The …

Targeted Therapy for the Treatment of Advanced Non-small Cell Lung Cancer*: A Review of the Epidermal Growth Factor Receptor Antagonists

GA Silvestri, MP Rivera - Chest, 2005 - search.proquest.com
Lung cancer is the most common cause of cancer death. The vast majority of patients
present with non-small cell lung cancer (NSCLC) in advanced inoperable stages. The …

[引用][C] Targeted Therapy for the Treatment of Advanced Non-small Cell Lung Cancer

GA Silvestri, MP Rivera - Chest, 2005 - cir.nii.ac.jp
Targeted Therapy for the Treatment of Advanced Non-small Cell Lung Cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists.

GA Silvestri, MP Rivera - Chest, 2005 - europepmc.org
Lung cancer is the most common cause of cancer death. The vast majority of patients
present with non-small cell lung cancer (NSCLC) in advanced inoperable stages. The …

Targeted Therapy for the Treatment of Advanced Non-small Cell Lung Cancer: A Review of the Epidermal Growth Factor Receptor Antagonists

GA Silvestri, MP Rivera - CHEST, 2005 - journal.chestnet.org
Lung cancer is the most common cause of cancer death. The vast majority of patients
present with non-small cell lung cancer (NSCLC) in advanced inoperable stages. The …

[引用][C] Targeted therapy for the treatment of advanced non-small cell lung cancer: A review of the epidermal growth factor receptor antagonists

GA SILVESTRI, MP RIVERA - Chest, 2005 - pascal-francis.inist.fr
Targeted therapy for the treatment of advanced non-small cell lung cancer : A review of the
epidermal growth factor receptor antagonists CNRS Inist Pascal-Francis CNRS Pascal and …

Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists

GA Silvestri, MP Rivera - Chest, 2005 - go.gale.com
Lung cancer is the most common cause of cancer death. The vast majority of patients
present with non-small cell lung cancer (NSCLC) in advanced inoperable stages. The …

Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists

GA Silvestri, MP Rivera - Chest, 2005 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the most common cause of cancer death. The vast majority of patients
present with non-small cell lung cancer (NSCLC) in advanced inoperable stages. The …

[引用][C] Targeted therapy for the treatment of advanced non-small cell lung cancer: A review of the epidermal growth factor receptor antagonists

GA SILVESTRI, MP RIVERA - Chest, 2005 - American College of Chest …